Skip to main
  1. Stocks
  2. GE HealthCare Technologies Inc
  3. Forecast
GEHC

GEHC Stock Forecast & Price Target

GEHC Analyst Ratings

Based on 19 analyst ratings
Buy
Strong Buy 26%
Buy 32%
Hold 42%
Sell 0%
Strong Sell 0%

Bulls say

GE HealthCare Techs is supported by a stronger-than-expected Q3'26 print, with 6.2% organic revenue growth, adjusted EPS above consensus, and a book-to-bill of 1.03x that appears to reflect backlog conversion more than demand softness. Broad-based strength across Imaging, Advanced Imaging Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics, especially PCS at +8.8% organic versus expectations for decline, reduces a major overhang and supports the view that the 2H'26 inflection is real. Management’s raised FY26 guide across organic growth, margins, EPS, and free cash flow, plus a 12% y/y backlog increase and improving pipeline, gives a credible path for momentum into 2027.

Bears say

GE HealthCare Techs is facing a negative setup because its growth depends on slower-than-expected backlog conversion, weaker commercial execution, and a sluggish shift toward recurring revenue, even though recurring streams make up about half of sales through servicing, diagnostics, and digital offerings. Tariffs and inflation are already pressuring profitability, with inflation a ~170bps headwind to adjusted EBIT margin in 3Q26 and management expecting FY27 impacts similar to FY26, limiting gross margin improvement and offsetting benefits from cost cuts and SOFIE. On top of that, low-single-digit revenue growth in the bear case, China weakness, hospital capital budget pressure, competition, supply-chain risk, and regulatory exposure all threaten earnings growth and shareholder returns.

GEHC has been analyzed by 19 analysts, with a consensus rating of Buy. 26% of analysts recommend a Strong Buy, 32% recommend Buy, 42% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of GE HealthCare Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.

GEHC Analyst Forecast & Price Prediction

Get the latest GEHC stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in GEHC

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About GE HealthCare Technologies Inc (GEHC) Forecast

Analysts have given GEHC a Buy based on their latest research and market trends.

According to 19 analysts, GEHC has a Buy consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $83.89, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $83.89, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

GE HealthCare Technologies Inc (GEHC)


GEHC Analyst Forecast & Price Prediction

Get the latest GEHC stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in GEHC

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover GEHC stock data and trends